Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in J Neurosurg

Retrieve available abstracts of 182 articles:
HTML format
Text format



Single Articles


    November 2018

  1. Preserve or sacrifice the stalk? Endocrinological outcomes, extent of resection, and recurrence rates following endoscopic endonasal resection of craniopharyngiomas.
    J Neurosurg. 2018 Nov 1:1-9. doi: 10.3171/2018.6.JNS18901.
    PubMed     Text format     Abstract available



  2. Endonasal endoscopic transsphenoidal resection of intrinsic third ventricular craniopharyngioma: surgical results.
    J Neurosurg. 2018 Nov 1:1-11. doi: 10.3171/2018.5.JNS18198.
    PubMed     Text format     Abstract available


    October 2018

  3. Harvey Cushing's craniopharyngioma treatment: Part 1. Identification and clinicopathological characterization of this challenging pituitary tumor.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18153.
    PubMed     Text format     Abstract available



  4. Harvey Cushing's craniopharyngioma treatment: Part 2. Surgical strategies and results of his pioneering series.
    J Neurosurg. 2018 Oct 1:1-15. doi: 10.3171/2018.5.JNS18154.
    PubMed     Text format     Abstract available



  5. Transcortical insular glioma resection: clinical outcome and predictors.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS18424.
    PubMed     Text format     Abstract available



  6. Ventricle contact is associated with lower survival and increased peritumoral perfusion in glioblastoma.
    J Neurosurg. 2018 Oct 1:1-7. doi: 10.3171/2018.5.JNS18340.
    PubMed     Text format     Abstract available



  7. A modern series of subdiaphragmatic craniopharyngiomas.
    J Neurosurg. 2018 Oct 1:1-6. doi: 10.3171/2018.4.JNS172330.
    PubMed     Text format     Abstract available



  8. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    J Neurosurg. 2018 Oct 1:1-11. doi: 10.3171/2018.4.JNS172909.
    PubMed     Text format     Abstract available


    September 2018
  9. LAVRADOR JP, Acharya S, Giamouriadis A, Vergani F, et al
    Letter to the Editor. Intermediate-risk meningioma and NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 28:1-3. doi: 10.3171/2018.4.JNS18811.
    PubMed     Text format    


  10. PUGLISI G, Sciortino T, Rossi M, Leonetti A, et al
    Preserving executive functions in nondominant frontal lobe glioma surgery: an intraoperative tool.
    J Neurosurg. 2018 Sep 28:1-7. doi: 10.3171/2018.4.JNS18393.
    PubMed     Text format     Abstract available


  11. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    Perioperative outcomes following reoperation for recurrent insular gliomas.
    J Neurosurg. 2018 Sep 21:1-7. doi: 10.3171/2018.4.JNS18375.
    PubMed     Text format     Abstract available


  12. RASSI MS, Prasad S, Can A, Pravdenkova S, et al
    Prognostic factors in the surgical treatment of intracanalicular primary optic nerve sheath meningiomas.
    J Neurosurg. 2018 Sep 21:1-8. doi: 10.3171/2018.4.JNS173080.
    PubMed     Text format     Abstract available


  13. HIRATA T, Kinoshita M, Tamari K, Seo Y, et al
    (11)C-methionine-(18)F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy.
    J Neurosurg. 2018 Sep 21:1-11. doi: 10.3171/2018.4.JNS1859.
    PubMed     Text format     Abstract available


  14. SUNDBLOM J, Nowinski D, Casar-Borota O, Ryttlefors M, et al
    Removal of giant intraosseous meningioma followed by cranioplasty using a custom-made bioceramic implant: case report.
    J Neurosurg. 2018 Sep 14:1-5. doi: 10.3171/2018.4.JNS1850.
    PubMed     Text format     Abstract available


  15. FOLARON M, Strawbridge R, Samkoe KS, Filan C, et al
    Elucidating the kinetics of sodium fluorescein for fluorescence-guided surgery of glioma.
    J Neurosurg. 2018 Sep 7:1-11. doi: 10.3171/2018.4.JNS172644.
    PubMed     Text format     Abstract available


  16. SERIZAWA T, Higuchi Y, Yamamoto M, Matsunaga S, et al
    Comparison of treatment results between 3- and 2-stage Gamma Knife radiosurgery for large brain metastases: a retrospective multi-institutional study.
    J Neurosurg. 2018 Sep 7:1-11. doi: 10.3171/2018.4.JNS172596.
    PubMed     Text format     Abstract available



  17. Erratum. Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2018 Sep 1:1. doi: 10.3171/2018.8.JNS161170.
    PubMed     Text format    


    August 2018
  18. JENKINSON MD, Weber DC, Haylock BJ, Sherratt FC, et al
    Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma.
    J Neurosurg. 2018 Aug 17:1-2. doi: 10.3171/2018.6.JNS181418.
    PubMed     Text format    


  19. HAN SJ, Morshed RA, Troncon I, Jordan KM, et al
    Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases.
    J Neurosurg. 2018 Aug 17:1-8. doi: 10.3171/2018.3.JNS172494.
    PubMed     Text format     Abstract available


  20. BROKINKEL B, Sicking J, Spille DC, Hess K, et al
    Letter to the Editor. Brain invasion and the risk for postoperative hemorrhage and neurological deterioration after meningioma surgery.
    J Neurosurg. 2018 Aug 10:1-3. doi: 10.3171/2018.5.JNS181287.
    PubMed     Text format    


  21. MASUDA Y, Akutsu H, Ishikawa E, Matsuda M, et al
    Evaluation of the extent of resection and detection of ischemic lesions with intraoperative MRI in glioma surgery: is intraoperative MRI superior to early postoperative MRI?
    J Neurosurg. 2018 Aug 10:1-8. doi: 10.3171/2018.3.JNS172516.
    PubMed     Text format     Abstract available


  22. HARA T, Akutsu H, Takano S, Kino H, et al
    Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation.
    J Neurosurg. 2018 Aug 3:1-10. doi: 10.3171/2018.3.JNS172528.
    PubMed     Text format     Abstract available



  23. Erratum. A prospective randomized trial of the optimal dose of mannitol for intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018;129:551-552.
    PubMed     Text format    


    July 2018
  24. SCHERER M, Jungk C, Gotz M, Kickingereder P, et al
    Early postoperative delineation of residual tumor after low-grade glioma resection by probabilistic quantification of diffusion-weighted imaging.
    J Neurosurg. 2018 Jul 27:1-9. doi: 10.3171/2018.2.JNS172951.
    PubMed     Text format     Abstract available


  25. PARK KJ, Kano H, Iyer A, Liu X, et al
    Gamma Knife stereotactic radiosurgery for cavernous sinus meningioma: long-term follow-up in 200 patients.
    J Neurosurg. 2018 Jul 20:1-10. doi: 10.3171/2018.2.JNS172361.
    PubMed     Text format     Abstract available


    June 2018
  26. LAGMAN C, Ong V, Nguyen T, Alkhalid Y, et al
    The Meningioma Vascularity Index: a volumetric analysis of flow voids to predict intraoperative blood loss in nonembolized meningiomas.
    J Neurosurg. 2018 Jun 22:1-6. doi: 10.3171/2018.1.JNS172724.
    PubMed     Text format     Abstract available


  27. INCEKARA F, Satoer D, Visch-Brink E, Vincent A, et al
    Changes in language white matter tract microarchitecture associated with cognitive deficits in patients with presumed low-grade glioma.
    J Neurosurg. 2018 Jun 8:1-9. doi: 10.3171/2017.12.JNS171681.
    PubMed     Text format     Abstract available


  28. HIDALGO ET, McQuinn MW, Wisoff JH
    Regression after subtotal resection of an optic pathway glioma in an adult without adjuvant therapy: case report.
    J Neurosurg. 2018 Jun 1:1-4. doi: 10.3171/2017.12.JNS172188.
    PubMed     Text format     Abstract available


  29. KONG B, Liu Y
    Letter to the Editor. How to provide intraoperative brain relaxation in patients undergoing craniotomy for supratentorial brain tumor resection.
    J Neurosurg. 2018 Jun 1:1-2. doi: 10.3171/2017.8.JNS172025.
    PubMed     Text format    


    May 2018
  30. OTTENHAUSEN M, Rumalla K, Younus I, Minkowitz S, et al
    Predictors of postoperative motor function in rolandic meningiomas.
    J Neurosurg. 2018 May 25:1-6. doi: 10.3171/2017.12.JNS172423.
    PubMed     Text format     Abstract available


  31. AGARWAL N, Gupta D
    Letter to the Editor. Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas: unanswered questions.
    J Neurosurg. 2018 May 25:1-2. doi: 10.3171/2018.3.JNS18598.
    PubMed     Text format    


  32. MARX S, Schroeder HWS
    Letter to the Editor. Transcranial versus endonasal approaches in tuberculum sellae meningioma surgery.
    J Neurosurg. 2018 May 25:1-2. doi: 10.3171/2018.2.JNS18282.
    PubMed     Text format    


  33. KIM KH, Kang SJ, Choi JW, Kong DS, et al
    Clinical and radiological outcomes of proactive Gamma Knife surgery for asymptomatic meningiomas compared with the natural course without intervention.
    J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.12.JNS171943.
    PubMed     Text format     Abstract available


  34. KONG DS, Hong CK, Hong SD, Nam DH, et al
    Selection of endoscopic or transcranial surgery for tuberculum sellae meningiomas according to specific anatomical features: a retrospective multicenter analysis (KOSEN-002).
    J Neurosurg. 2018 May 18:1-10. doi: 10.3171/2017.11.JNS171337.
    PubMed     Text format     Abstract available


  35. PRIETO R, Pascual JM, Barrios L
    Letter to the Editor. The role of preoperative MRI in predicting craniopharyngioma behavior.
    J Neurosurg. 2018 May 4:1-3. doi: 10.3171/2017.11.JNS172880.
    PubMed     Text format    


  36. AHLUWALIA M, Barnett GH, Deng D, Tatter SB, et al
    Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.
    J Neurosurg. 2018 May 4:1-8. doi: 10.3171/2017.11.JNS171273.
    PubMed     Text format     Abstract available


  37. MAGILL ST, Lee DS, Yen AJ, Lucas CG, et al
    Surgical outcomes after reoperation for recurrent skull base meningiomas.
    J Neurosurg. 2018 May 4:1-8. doi: 10.3171/2017.11.JNS172278.
    PubMed     Text format     Abstract available


  38. LIOUTA E, Stranjalis G, Kalyvas AV, Koutsarnakis C, et al
    Parietal association deficits in patients harboring parietal lobe gliomas: a prospective study.
    J Neurosurg. 2018 May 4:1-7. doi: 10.3171/2017.12.JNS171799.
    PubMed     Text format     Abstract available


  39. YAMASHITA S, Yokogami K, Matsumoto F, Saito K, et al
    MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
    J Neurosurg. 2018 May 4:1-9. doi: 10.3171/2017.11.JNS171710.
    PubMed     Text format     Abstract available


    April 2018
  40. HIMES BT, Ruff MW, Van Gompel JJ, Park SS, et al
    Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with dabrafenib: case report.
    J Neurosurg. 2018 Apr 27:1-5. doi: 10.3171/2017.11.JNS172373.
    PubMed     Text format     Abstract available


  41. LIU F, Chen W, Chen J
    Letter to the Editor. Resection for WHO Grade III gliomas.
    J Neurosurg. 2018 Apr 27:1-2. doi: 10.3171/2017.10.JNS172459.
    PubMed     Text format    


  42. HESS K, Spille DC, Adeli A, Sporns PB, et al
    Brain invasion and the risk of seizures in patients with meningioma.
    J Neurosurg. 2018 Apr 27:1-8. doi: 10.3171/2017.11.JNS172265.
    PubMed     Text format     Abstract available


  43. MORSHED RA, Young JS, Han SJ, Hervey-Jumper SL, et al
    The transcortical equatorial approach for gliomas of the mesial temporal lobe: techniques and functional outcomes.
    J Neurosurg. 2018 Apr 20:1-9. doi: 10.3171/2017.10.JNS172055.
    PubMed     Text format     Abstract available


  44. JHAVERI J, Chowdhary M, Zhang X, Press RH, et al
    Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
    J Neurosurg. 2018 Apr 20:1-7. doi: 10.3171/2017.9.JNS171735.
    PubMed     Text format     Abstract available


  45. VOGELBAUM MA, Brewer C, Barnett GH, Mohammadi AM, et al
    First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1.
    J Neurosurg. 2018 Apr 13:1-10. doi: 10.3171/2017.10.JNS171845.
    PubMed     Text format     Abstract available


  46. BASHIR A, Brennum J, Broholm H, Law I, et al
    The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[(18)F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    J Neurosurg. 2018 Apr 6:1-14. doi: 10.3171/2017.8.JNS171577.
    PubMed     Text format     Abstract available


  47. CHEN WC, Magill ST, Wu A, Vasudevan HN, et al
    Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    J Neurosurg. 2018 Apr 6:1-8. doi: 10.3171/2017.9.JNS171609.
    PubMed     Text format     Abstract available


    March 2018
  48. AMELOT A, van Effenterre R, Kalamarides M, Cornu P, et al
    Natural history of cavernous sinus meningiomas.
    J Neurosurg. 2018 Mar 30:1-8. doi: 10.3171/2017.7.JNS17662.
    PubMed     Text format     Abstract available


  49. BARZILAI O, Ben Moshe S, Sitt R, Sela G, et al
    Improvement in cognitive function after surgery for low-grade glioma.
    J Neurosurg. 2018 Mar 23:1-9. doi: 10.3171/2017.9.JNS17658.
    PubMed     Text format     Abstract available


  50. KARSY M, Guan J, Huang LE
    Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
    J Neurosurg. 2018 Mar 16:1-11. doi: 10.3171/2017.9.JNS172036.
    PubMed     Text format     Abstract available


  51. KUROGI R, Nakamizo A, Suzuki SO, Mizoguchi M, et al
    Inhibition of glioblastoma cell invasion by hsa-miR-145-5p and hsa-miR-31-5p co-overexpression in human mesenchymal stem cells.
    J Neurosurg. 2018 Mar 9:1-12. doi: 10.3171/2017.8.JNS1788.
    PubMed     Text format     Abstract available


    February 2018
  52. ROSSI M, Fornia L, Puglisi G, Leonetti A, et al
    Assessment of the praxis circuit in glioma surgery to reduce the incidence of postoperative and long-term apraxia: a new intraoperative test.
    J Neurosurg. 2018 Feb 23:1-11. doi: 10.3171/2017.7.JNS17357.
    PubMed     Text format     Abstract available


  53. WANG L, Chen W, Liu F, Zhang LF, et al
    Letter to the Editor. Multiple meningiomas.
    J Neurosurg. 2018 Feb 23:1-2. doi: 10.3171/2017.8.JNS172004.
    PubMed     Text format    


  54. VAN BAARSEN K, Roth J, Serova N, Packer RJ, et al
    Optic pathway-hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature.
    J Neurosurg. 2018 Feb 9:1-9. doi: 10.3171/2017.8.JNS163085.
    PubMed     Text format     Abstract available


    January 2018
  55. SADIK ZHA, Lie ST, Leenstra S, Hanssens PEJ, et al
    Volumetric changes and clinical outcome for petroclival meningiomas after primary treatment with Gamma Knife radiosurgery.
    J Neurosurg. 2018 Jan 26:1-7. doi: 10.3171/2017.7.JNS17380.
    PubMed     Text format     Abstract available


  56. LIU F, Chen W, Chen J
    Letter to the Editor. Is there any relationship between estrogen receptor/progesterone receptor status and recurrence of meningioma?
    J Neurosurg. 2018 Jan 26:1-3. doi: 10.3171/2017.9.JNS172219.
    PubMed     Text format    


  57. XUE FS, Yang GZ, Li HX, Liu YY, et al
    Letter to the Editor. Is preoperative hypoalbuminemia really a risk factor associated with acute kidney injury and mortality after brain tumor surgery?
    J Neurosurg. 2018 Jan 19:1-3. doi: 10.3171/2017.7.JNS171654.
    PubMed     Text format    


  58. SHAKIR SI, Souhami L, Petrecca K, Mansure JJ, et al
    Prognostic factors for progression in atypical meningioma.
    J Neurosurg. 2018 Jan 19:1-9. doi: 10.3171/2017.6.JNS17120.
    PubMed     Text format     Abstract available


  59. SUEHIRO S, Ohnishi T, Yamashita D, Kohno S, et al
    Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
    J Neurosurg. 2018 Jan 19:1-13. doi: 10.3171/2017.6.JNS162398.
    PubMed     Text format     Abstract available


  60. LUEDI MM, Singh SK, Mosley JC, Hassan ISA, et al
    Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
    J Neurosurg. 2018 Jan 12:1-10. doi: 10.3171/2017.7.JNS17668.
    PubMed     Text format     Abstract available


  61. SUERO MOLINA E, Schipmann S, Mueller I, Wolfer J, et al
    Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.
    J Neurosurg. 2018 Jan 12:1-8. doi: 10.3171/2017.7.JNS171312.
    PubMed     Text format     Abstract available


  62. PATIBANDLA MR, Lee CC, Tata A, Addagada GC, et al
    Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation.
    J Neurosurg. 2018 Jan 5:1-11. doi: 10.3171/2017.6.JNS17993.
    PubMed     Text format     Abstract available


  63. GOLDMAN DA, Hovinga K, Reiner AS, Esquenazi Y, et al
    The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
    J Neurosurg. 2018 Jan 5:1-9. doi: 10.3171/2017.6.JNS17393.
    PubMed     Text format     Abstract available


  64. DIAO K, Bian SX, Routman DM, Yu C, et al
    Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects.
    J Neurosurg. 2018 Jan 5:1-10. doi: 10.3171/2017.7.JNS171286.
    PubMed     Text format     Abstract available


    December 2017
  65. SHAN B, Zhang J, Xu J
    Letter to the Editor. Function outcome related to aggressive surgery for meningioma?
    J Neurosurg. 2017 Dec 22:1-2. doi: 10.3171/2017.6.JNS171089.
    PubMed     Text format    


  66. RINALDO L, Brown D, Lanzino G, Parney IF, et al
    Outcomes following cerebrospinal fluid shunting in high-grade glioma patients.
    J Neurosurg. 2017 Dec 22:1-13. doi: 10.3171/2017.6.JNS17859.
    PubMed     Text format     Abstract available


  67. FERROLI P, Broggi M
    Letter to the Editor. Outcome prediction in brain tumor surgery.
    J Neurosurg. 2017 Dec 15:1-3. doi: 10.3171/2017.5.JNS171098.
    PubMed     Text format    


  68. PRASAD GL
    Letter to the Editor. Usefulness of 5-ALA in resection of intracranial meningiomas.
    J Neurosurg. 2017 Dec 1:1-3. doi: 10.3171/2017.6.JNS17634.
    PubMed     Text format    


  69. SHEEHAN JP
    Journal of Neurosurgery's Top 25 highly cited articles on Gamma Knife surgery for meningioma.
    J Neurosurg. 2017;127.
    PubMed     Text format    


    November 2017
  70. SHASBY G
    Erratum. Bevacizumab and irinotecan therapy in glioblastoma multiforme: a series of 13 cases.
    J Neurosurg. 2017 Nov 24:1. doi: 10.3171/2017.8.JNS08268.
    PubMed     Text format    


  71. YAMAGUCHI F, Ten H, Higuchi T, Omura T, et al
    An intraoperative motor tract positioning method in brain tumor surgery: technical note.
    J Neurosurg. 2017 Nov 24:1-7. doi: 10.3171/2017.5.JNS162978.
    PubMed     Text format     Abstract available


  72. NEIL D
    Letter to the Editor. Puzzling posology: was the bevacizumab regimen in recurrent glioblastoma misreported?
    J Neurosurg. 2017 Nov 24:1. doi: 10.3171/2017.5.JNS171208.
    PubMed     Text format    


  73. OMAY SB, Almeida JP, Chen YN, Shetty SR, et al
    Is the chiasm-pituitary corridor size important for achieving gross-total resection during endonasal endoscopic resection of craniopharyngiomas?
    J Neurosurg. 2017 Nov 24:1-6. doi: 10.3171/2017.6.JNS163188.
    PubMed     Text format     Abstract available


  74. MAO L, Whitehead CA, Paradiso L, Kaye AH, et al
    Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.
    J Neurosurg. 2017 Nov 17:1-13. doi: 10.3171/2017.5.JNS17845.
    PubMed     Text format     Abstract available


  75. SOUTHWELL DG, Birk HS, Han SJ, Li J, et al
    Resection of gliomas deemed inoperable by neurosurgeons based on preoperative imaging studies.
    J Neurosurg. 2017 Nov 10:1-9. doi: 10.3171/2017.5.JNS17166.
    PubMed     Text format     Abstract available


  76. ZHENG SH, Huang JL, Chen M, Wang BL, et al
    Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
    J Neurosurg. 2017 Nov 3:1-10. doi: 10.3171/2017.3.JNS161648.
    PubMed     Text format     Abstract available


    October 2017
  77. KIESEL B, Mischkulnig M, Woehrer A, Martinez-Moreno M, et al
    Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
    J Neurosurg. 2017 Oct 27:1-13. doi: 10.3171/2017.4.JNS162991.
    PubMed     Text format     Abstract available


  78. FIGUEROA JM, Carter BS
    Detection of glioblastoma in biofluids.
    J Neurosurg. 2017 Oct 20:1-7. doi: 10.3171/2017.3.JNS162280.
    PubMed     Text format     Abstract available


  79. YUE Q, Yu Y, Shi Z, Wang Y, et al
    Prediction of BRAF mutation status of craniopharyngioma using magnetic resonance imaging features.
    J Neurosurg. 2017 Oct 6:1-8. doi: 10.3171/2017.4.JNS163113.
    PubMed     Text format     Abstract available


  80. OPOKU-DARKO M, Lang ST, Artindale J, Cairncross JG, et al
    Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
    J Neurosurg. 2017 Oct 6:1-8. doi: 10.3171/2017.3.JNS17159.
    PubMed     Text format     Abstract available


  81. ROGERS L, Zhang P, Vogelbaum MA, Perry A, et al
    Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539.
    J Neurosurg. 2017 Oct 6:1-13. doi: 10.3171/2016.11.JNS161170.
    PubMed     Text format     Abstract available


    September 2017
  82. ABEL TJ, Barrash J, Tranel D
    Letter to the Editor. Neuropsychological impairment and quality of life after skull base meningioma resection: size and location matter.
    J Neurosurg. 2017 Sep 29:1-2. doi: 10.3171/2017.4.JNS17740.
    PubMed     Text format    


  83. DHO YS, Kim YH, Se YB, Han DH, et al
    Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor.
    J Neurosurg. 2017 Sep 29:1-9. doi: 10.3171/2017.4.JNS162143.
    PubMed     Text format     Abstract available


  84. ANGELOV L, Mohammadi AM, Bennett EE, Abbassy M, et al
    Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases >/= 2 cm.
    J Neurosurg. 2017 Sep 22:1-17. doi: 10.3171/2017.3.JNS162532.
    PubMed     Text format     Abstract available


  85. FUJII Y, Muragaki Y, Maruyama T, Nitta M, et al
    Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    J Neurosurg. 2017 Sep 8:1-9. doi: 10.3171/2017.3.JNS162383.
    PubMed     Text format     Abstract available


  86. ALMEIDA JP, Omay SB, Shetty SR, Chen YN, et al
    Transorbital endoscopic eyelid approach for resection of sphenoorbital meningiomas with predominant hyperostosis: report of 2 cases.
    J Neurosurg. 2017 Sep 1:1-11. doi: 10.3171/2017.3.JNS163110.
    PubMed     Text format     Abstract available


  87. HIRAYAMA R, Kinoshita M, Arita H, Kagawa N, et al
    Voxel-based lesion mapping of meningioma: a comprehensive lesion location mapping of 260 lesions.
    J Neurosurg. 2017 Sep 1:1-6. doi: 10.3171/2017.3.JNS17169.
    PubMed     Text format     Abstract available


  88. MEHTA GU, Zenonos G, Patibandla MR, Lin CJ, et al
    Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study.
    J Neurosurg. 2017 Sep 1:1-7. doi: 10.3171/2017.3.JNS163008.
    PubMed     Text format     Abstract available


    August 2017
  89. ZUBATKINA I, Ivanov P
    Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.
    J Neurosurg. 2017 Aug 25:1-12. doi: 10.3171/2017.1.JNS162075.
    PubMed     Text format     Abstract available


  90. HUA L, Zhu H, Li J, Tang H, et al
    Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    J Neurosurg. 2017 Aug 18:1-9. doi: 10.3171/2017.2.JNS162566.
    PubMed     Text format     Abstract available


  91. BRAGSTAD S, Flatebo M, Natvig GK, Eide GE, et al
    Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    J Neurosurg. 2017 Aug 18:1-13. doi: 10.3171/2017.2.JNS161659.
    PubMed     Text format     Abstract available


  92. KALOSHI G, Petrela M
    Letter to the Editor. An extent of resection threshold for recurrent glioblastoma: why wait until recurrence?
    J Neurosurg. 2017 Aug 18:1. doi: 10.3171/2017.6.JNS14868.
    PubMed     Text format    


  93. KOTECHA R, Miller JA, Venur VA, Mohammadi AM, et al
    Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    J Neurosurg. 2017 Aug 11:1-10. doi: 10.3171/2017.1.JNS162797.
    PubMed     Text format     Abstract available


    July 2017
  94. OUSHY S, Sillau SH, Ney DE, Damek DM, et al
    New-onset seizure during and after brain tumor excision: a risk assessment analysis.
    J Neurosurg. 2017 Jul 28:1-6. doi: 10.3171/2017.2.JNS162315.
    PubMed     Text format     Abstract available


  95. LAU D, Hervey-Jumper SL, Han SJ, Berger MS, et al
    Intraoperative perception and estimates on extent of resection during awake glioma surgery: overcoming the learning curve.
    J Neurosurg. 2017 Jul 21:1-9. doi: 10.3171/2017.1.JNS161811.
    PubMed     Text format     Abstract available


  96. PAVLOV V, Varlet P, Chretien F, Nguyen G, et al
    Letter to the Editor. Expression of tissue (pro)renin receptor and concentrations of its soluble form in CSF in adult diffuse gliomas.
    J Neurosurg. 2017 Jul 21:1-3. doi: 10.3171/2017.2.JNS17254.
    PubMed     Text format    


  97. TSERMOULAS G, Turel MK, Wilcox JT, Shultz D, et al
    Management of multiple meningiomas.
    J Neurosurg. 2017 Jul 21:1-7. doi: 10.3171/2017.2.JNS162608.
    PubMed     Text format     Abstract available


  98. ORTON A, Frandsen J, Jensen R, Shrieve DC, et al
    Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
    J Neurosurg. 2017 Jul 21:1-6. doi: 10.3171/2017.2.JNS162282.
    PubMed     Text format     Abstract available


  99. OMAY SB, Chen YN, Almeida JP, Ruiz-Trevino AS, et al
    Do craniopharyngioma molecular signatures correlate with clinical characteristics?
    J Neurosurg. 2017 Jul 14:1-6. doi: 10.3171/2017.1.JNS162232.
    PubMed     Text format     Abstract available


  100. CONNER AK, Burks JD, Baker CM, Smitherman AD, et al
    Method for temporal keyhole lobectomies in resection of low- and high-grade gliomas.
    J Neurosurg. 2017 Jul 7:1-8. doi: 10.3171/2016.12.JNS162168.
    PubMed     Text format     Abstract available


    June 2017
  101. MORSHED RA, Han SJ, Lau D, Berger MS, et al
    Wavelength-specific lighted suction instrument for 5-aminolevulinic acid fluorescence-guided resection of deep-seated malignant glioma: technical note.
    J Neurosurg. 2017 Jun 30:1-6. doi: 10.3171/2017.1.JNS161949.
    PubMed     Text format     Abstract available


  102. AKYERLI CB, Yuksel S, Can O, Erson-Omay EZ, et al
    Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    J Neurosurg. 2017 Jun 16:1-13. doi: 10.3171/2016.11.JNS16973.
    PubMed     Text format     Abstract available


  103. KIM D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, et al
    Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
    J Neurosurg. 2017 Jun 16:1-10. doi: 10.3171/2016.11.JNS16913.
    PubMed     Text format     Abstract available


  104. SHAH AH, Jusue-Torres I, Ivan ME, Komotar RJ, et al
    Pathogens and glioma: a history of unexpected discoveries ushering in novel therapy.
    J Neurosurg. 2017 Jun 9:1-8. doi: 10.3171/2016.12.JNS162123.
    PubMed     Text format     Abstract available


  105. MANDA SV, Kataria Y, Tatireddy BR, Ramakrishnan B, et al
    Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    J Neurosurg. 2017 Jun 2:1-11. doi: 10.3171/2016.11.JNS161187.
    PubMed     Text format     Abstract available


    May 2017
  106. XU DS, Awad AW, Mehalechko C, Wilson JR, et al
    An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
    J Neurosurg. 2017 May 26:1-7. doi: 10.3171/2016.12.JNS161682.
    PubMed     Text format     Abstract available


  107. KIM K, Bang JY, Kim SO, Kim S, et al
    Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study.
    J Neurosurg. 2017 May 5:1-8. doi: 10.3171/2016.11.JNS162237.
    PubMed     Text format     Abstract available


  108. REN Q, He M, Xu J
    Letter to the Editor. Does preoperative NLR predict brain metastasis resections outcome?
    J Neurosurg. 2017 May 5. doi: 10.3171/2016.12.JNS163096.
    PubMed     Text format    


  109. MURATA D, Mineharu Y, Arakawa Y, Liu B, et al
    High programmed cell death 1 ligand-1 expression: association with CD8+ T-cell infiltration and poor prognosis in human medulloblastoma.
    J Neurosurg. 2017 May 5:1-7. doi: 10.3171/2016.11.JNS16991.
    PubMed     Text format     Abstract available


    April 2017
  110. SAITO T, Sugiyama K, Takeshima Y, Amatya VJ, et al
    Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    J Neurosurg. 2017 Apr 21:1-6. doi: 10.3171/2016.11.JNS162326.
    PubMed     Text format     Abstract available


  111. COTE DJ, Balak N, Brennum J, Holsgrove DT, et al
    Ethical difficulties in the innovative surgical treatment of patients with recurrent glioblastoma multiforme.
    J Neurosurg. 2017 Apr 21:1-6. doi: 10.3171/2016.11.JNS162488.
    PubMed     Text format    


  112. WANG W, Cho HY, Rosenstein-Sisson R, Marin Ramos NI, et al
    Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model.
    J Neurosurg. 2017 Apr 14:1-6. doi: 10.3171/2016.11.JNS161212.
    PubMed     Text format     Abstract available


  113. LEE JY, Pierce JT, Thawani JP, Zeh R, et al
    Near-infrared fluorescent image-guided surgery for intracranial meningioma.
    J Neurosurg. 2017 Apr 7:1-11. doi: 10.3171/2016.10.JNS161636.
    PubMed     Text format     Abstract available


  114. YAO PS, Zheng SF, Wang F, Kang DZ, et al
    Surgery guided with intraoperative electrocorticography in patients with low-grade glioma and refractory seizures.
    J Neurosurg. 2017 Apr 7:1-6. doi: 10.3171/2016.11.JNS161296.
    PubMed     Text format     Abstract available


  115. MARX S, Clemens S, Schroeder HW
    The value of endoscope assistance during transcranial surgery for tuberculum sellae meningiomas.
    J Neurosurg. 2017 Apr 7:1-8. doi: 10.3171/2016.11.JNS16713.
    PubMed     Text format     Abstract available


    March 2017
  116. KARSY M, Burnett B, Di Ieva A, Cusimano MD, et al
    Microvascularization of Grade I meningiomas: effect on tumor volume, blood loss, and patient outcome.
    J Neurosurg. 2017 Mar 31:1-10. doi: 10.3171/2016.10.JNS161825.
    PubMed     Text format     Abstract available


  117. THOMAS JG, Parker Kerrigan BC, Hossain A, Gumin J, et al
    Ionizing radiation augments glioma tropism of mesenchymal stem cells.
    J Neurosurg. 2017 Mar 31:1-9. doi: 10.3171/2016.9.JNS16278.
    PubMed     Text format     Abstract available


  118. KOLAKSHYAPATI M, Adhikari RB, Karlowee V, Takayasu T, et al
    Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    J Neurosurg. 2017 Mar 31:1-12. doi: 10.3171/2016.10.JNS161694.
    PubMed     Text format     Abstract available


  119. TULEASCA C, Negretti L, Faouzi M, Magaddino V, et al
    Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
    J Neurosurg. 2017 Mar 24:1-10. doi: 10.3171/2016.10.JNS161480.
    PubMed     Text format     Abstract available


  120. COHEN-INBAR O, Tata A, Moosa S, Lee CC, et al
    Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation.
    J Neurosurg. 2017 Mar 24:1-11. doi: 10.3171/2016.11.JNS161402.
    PubMed     Text format     Abstract available


  121. SUERO MOLINA E, Wolfer J, Ewelt C, Ehrhardt A, et al
    Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
    J Neurosurg. 2017 Mar 24:1-7. doi: 10.3171/2016.11.JNS161072.
    PubMed     Text format     Abstract available


  122. TIETZE A, Choi C, Mickey B, Maher EA, et al
    Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting.
    J Neurosurg. 2017 Mar 3:1-8. doi: 10.3171/2016.10.JNS161793.
    PubMed     Text format     Abstract available


  123. PEETERS S, Pages M, Gauchotte G, Miquel C, et al
    Interactions between glioma and pregnancy: insight from a 52-case multicenter series.
    J Neurosurg. 2017 Mar 3:1-11. doi: 10.3171/2016.10.JNS16710.
    PubMed     Text format     Abstract available


    February 2017
  124. MITTAL S, Klinger NV, Michelhaugh SK, Barger GR, et al
    Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
    J Neurosurg. 2017 Feb 24:1-8. doi: 10.3171/2016.9.JNS16452.
    PubMed     Text format     Abstract available


  125. MASTORAKOS P, Hays MA, Caruso JP, Chen CJ, et al
    Transtentorial dissemination of optic nerve glioblastoma: case report.
    J Neurosurg. 2017 Feb 17:1-8. doi: 10.3171/2016.10.JNS161443.
    PubMed     Text format     Abstract available


  126. WOLF A, Kvint S, Chachoua A, Pavlick A, et al
    Toward the complete control of brain metastases using surveillance screening and stereotactic radiosurgery.
    J Neurosurg. 2017 Feb 17:1-9. doi: 10.3171/2016.10.JNS161036.
    PubMed     Text format     Abstract available


  127. DENG L, Zhou H, Xiao B, Bai HX, et al
    Letter to the Editor: Specificity and validity of putaminal involvement as a prognostic factor in Grade II insular gliomas.
    J Neurosurg. 2017 Feb 10:1-2. doi: 10.3171/2016.9.JNS162311.
    PubMed     Text format    


  128. ZWECKBERGER K, Hallek E, Vogt L, Giese H, et al
    Prospective analysis of neuropsychological deficits following resection of benign skull base meningiomas.
    J Neurosurg. 2017 Feb 10:1-7. doi: 10.3171/2016.10.JNS161936.
    PubMed     Text format     Abstract available


  129. D'AMICO RS, Banu MA, Petridis P, Bercow AS, et al
    Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas.
    J Neurosurg. 2017 Feb 10:1-11. doi: 10.3171/2016.10.JNS161982.
    PubMed     Text format     Abstract available


  130. GATTERBAUER B, Gevsek S, Hoftberger R, Lutgendorf-Caucig C, et al
    Multimodal treatment of parasagittal meningiomas: a single-center experience.
    J Neurosurg. 2017 Feb 3:1-8. doi: 10.3171/2016.9.JNS161859.
    PubMed     Text format     Abstract available


    January 2017
  131. BANDER ED, Singh H, Ogilvie CB, Cusic RC, et al
    Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas in a similar cohort of patients.
    J Neurosurg. 2017 Jan 27:1-9. doi: 10.3171/2016.9.JNS16823.
    PubMed     Text format     Abstract available


  132. JEHNA M, Becker J, Zaar K, von Campe G, et al
    Symmetry of the arcuate fasciculus and its impact on language performance of patients with brain tumors in the language-dominant hemisphere.
    J Neurosurg. 2017 Jan 27:1-10. doi: 10.3171/2016.9.JNS161281.
    PubMed     Text format     Abstract available


  133. CONWAY N, Wildschuetz N, Moser T, Bulubas L, et al
    Cortical plasticity of motor-eloquent areas measured by navigated transcranial magnetic stimulation in patients with glioma.
    J Neurosurg. 2017 Jan 20:1-11. doi: 10.3171/2016.9.JNS161595.
    PubMed     Text format     Abstract available


  134. KANO H, Morales-Restrepo A, Iyer A, Weiner GM, et al
    Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
    J Neurosurg. 2017 Jan 20:1-9. doi: 10.3171/2016.9.JNS161011.
    PubMed     Text format     Abstract available


  135. LEE EJ, Kim JH, Park ES, Kim YH, et al
    A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas.
    J Neurosurg. 2017 Jan 13:1-10. doi: 10.3171/2016.9.JNS161669.
    PubMed     Text format     Abstract available


  136. TAKAKURA T, Muragaki Y, Tamura M, Maruyama T, et al
    Navigated transcranial magnetic stimulation for glioma removal: prognostic value in motor function recovery from postsurgical neurological deficits.
    J Neurosurg. 2017 Jan 6:1-15. doi: 10.3171/2016.8.JNS16442.
    PubMed     Text format     Abstract available


  137. COHEN-INBAR O, Shih HH, Xu Z, Schlesinger D, et al
    The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
    J Neurosurg. 2017 Jan 6:1-8. doi: 10.3171/2016.9.JNS161585.
    PubMed     Text format     Abstract available


  138. MISSIOS S, Bekelis K
    Emergency department evaluation and 30-day readmission after craniotomy for primary brain tumor resection in New York State.
    J Neurosurg. 2017 Jan 6:1-6. doi: 10.3171/2016.9.JNS161575.
    PubMed     Text format     Abstract available


  139. SOUTHWELL DG, Riva M, Jordan K, Caverzasi E, et al
    Language outcomes after resection of dominant inferior parietal lobule gliomas.
    J Neurosurg. 2017 Jan 6:1-9. doi: 10.3171/2016.8.JNS16443.
    PubMed     Text format     Abstract available


  140. PRIETO R, Pascual JM
    Norman M. Dott, master of hypothalamic craniopharyngioma surgery: the decisive mentoring of Harvey Cushing and Percival Bailey at Peter Bent Brigham Hospital.
    J Neurosurg. 2017 Jan 6:1-14. doi: 10.3171/2016.9.JNS16702.
    PubMed     Text format     Abstract available


  141. BIJANGI-VISHEHSARAEI K, Reza Saadatzadeh M, Wang H, Nguyen A, et al
    Sulforaphane suppresses the growth of glioblastoma cells, glioblastoma stem cell-like spheroids, and tumor xenografts through multiple cell signaling pathways.
    J Neurosurg. 2017 Jan 6:1-12. doi: 10.3171/2016.8.JNS161197.
    PubMed     Text format     Abstract available


  142. KOUCHI M, Shibayama Y, Ogawa D, Miyake K, et al
    (Pro)renin receptor is crucial for glioma development via the Wnt/beta-catenin signaling pathway.
    J Neurosurg. 2017 Jan 6:1-10. doi: 10.3171/2016.9.JNS16431.
    PubMed     Text format     Abstract available


  143. MEIER R, Porz N, Knecht U, Loosli T, et al
    Automatic estimation of extent of resection and residual tumor volume of patients with glioblastoma.
    J Neurosurg. 2017 Jan 6:1-9. doi: 10.3171/2016.9.JNS16146.
    PubMed     Text format     Abstract available


  144. MOTOMURA K, Natsume A, Iijima K, Kuramitsu S, et al
    Surgical benefits of combined awake craniotomy and intraoperative magnetic resonance imaging for gliomas associated with eloquent areas.
    J Neurosurg. 2017 Jan 6:1-8. doi: 10.3171/2016.9.JNS16152.
    PubMed     Text format     Abstract available


    December 2016
  145. SHRIVASTAVA A, Arora P, Khare A, Goel G, et al
    Central nervous system filariasis masquerading as a glioma: case report.
    J Neurosurg. 2016 Dec 23:1-3. doi: 10.3171/2016.9.JNS161092.
    PubMed     Text format     Abstract available


  146. SRINIVASAN A
    Letter to the Editor: Recurrent or residual craniopharyngioma: management options.
    J Neurosurg. 2016 Dec 23:1. doi: 10.3171/2016.9.JNS162481.
    PubMed     Text format    


  147. GRAILLON T, Romano D, Defilles C, Saveanu A, et al
    Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  148. RAHEJA A, Colman H, Palmer CA, Couldwell WT, et al
    Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  149. CHEN YR, Ugiliweneza B, Burton E, Woo SY, et al
    The effect of postoperative infection on survival in patients with glioblastoma.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  150. SERIZAWA T, Higuchi Y, Nagano O, Matsuda S, et al
    Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  151. MITSUYA K, Nakasu Y, Kurakane T, Hayashi N, et al
    Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  152. DONG P, Perez-Andujar A, Pinnaduwage D, Braunstein S, et al
    Dosimetric characterization of hypofractionated Gamma Knife radiosurgery of large or complex brain tumors versus linear accelerator-based treatments.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  153. DUMA CM, Kim BS, Chen PV, Plunkett ME, et al
    Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  154. LESTER-COLL NH, Dosoretz AP, Magnuson WJ, Laurans MS, et al
    Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  155. SPECKTER H, Bido J, Hernandez G, Mejia DR, et al
    Prognostic value of diffusion tensor imaging parameters for Gamma Knife radiosurgery in meningiomas.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  156. VALERY CA, Faillot M, Lamproglou I, Golmard JL, et al
    Grade II meningiomas and Gamma Knife radiosurgery: analysis of success and failure to improve treatment paradigm.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  157. MIX M, Elmarzouky R, O'Connor T, Plunkett R, et al
    Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  158. EL-SHEHABY AM, Reda WA, Abdel Karim KM, Emad Eldin RM, et al
    Single-session Gamma Knife radiosurgery for optic pathway/hypothalamic gliomas.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  159. BIAN SX, Routman D, Liu J, Yang D, et al
    Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  160. KAWABE T, Yamamoto M, Sato Y, Yomo S, et al
    Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


  161. KOISO T, Yamamoto M, Kawabe T, Watanabe S, et al
    Follow-up results of brain metastasis patients undergoing repeat Gamma Knife radiosurgery.
    J Neurosurg. 2016;125.
    PubMed     Text format     Abstract available


    November 2016
  162. STRICKLAND MR, Gill CM, Nayyar N, D'Andrea MR, et al
    Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  163. JOHN JK, Robin AM, Pabaney AH, Rammo RA, et al
    Complications of ventricular entry during craniotomy for brain tumor resection.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


    October 2016
  164. ZHANG JT
    Erratum: Foramen magnum meningiomas: surgical results and risks predicting poor outcomes based on a modified classification.
    J Neurosurg. 2016.
    PubMed     Text format    


  165. BETTE S, Gempt J, Huber T, Delbridge C, et al
    FLAIR signal increase of the fluid within the resection cavity after glioma surgery: generally valid as early recurrence marker?
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  166. VAIOS EJ, Nahed BV, Muzikansky A, Fathi AT, et al
    Bone marrow response as a potential biomarker of outcomes in glioblastoma patients.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  167. NEIRA JA, Ung TH, Sims JS, Malone HR, et al
    Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  168. CHERNOV M
    Letter to the Editor: Seizures and invasive meningiomas.
    J Neurosurg. 2016.
    PubMed     Text format    


    September 2016
  169. RAHMAN M, Abbatematteo J, De Leo EK, Kubilis PS, et al
    The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  170. AZARNOUSH H, Siar S, Sawaya R, Zhrani GA, et al
    The force pyramid: a spatial analysis of force application during virtual reality brain tumor resection.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  171. BURKS JD, Bonney PA, Conner AK, Glenn CA, et al
    A method for safely resecting anterior butterfly gliomas: the surgical anatomy of the default mode network and the relevance of its preservation.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  172. BANSAL A, Sinha S
    Letter to the Editor: Resection of olfactory groove meningiomas.
    J Neurosurg. 2016.
    PubMed     Text format    


  173. BAGSHAW HP, Burt LM, Jensen RL, Suneja G, et al
    Adjuvant radiotherapy for atypical meningiomas.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


    May 2016
  174. KRISHT KM, Palmer CA, Couldwell WT
    Multiple osteomas of the falx cerebri and anterior skull base: case report.
    J Neurosurg. 2016;124:1339-42.
    PubMed     Text format     Abstract available


  175. ZOU Z, Yin Y, Lin J, Hsu LC, et al
    Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3.
    J Neurosurg. 2016;124:1310-8.
    PubMed     Text format     Abstract available


  176. FAUST K, Vajkoczy P
    Distinct displacements of the optic radiation based on tumor location revealed using preoperative diffusion tensor imaging.
    J Neurosurg. 2016;124:1343-52.
    PubMed     Text format     Abstract available


    March 2016
  177. LITTLE AS, Kelly DF, Barkhoudarian G
    Letter to the Editor: Transsphenoidal surgery for nonfunctioning adenomas.
    J Neurosurg. 2016.
    PubMed     Text format    


  178. TAMURA Y, Ogawa H, Kapeller C, Prueckl R, et al
    Passive language mapping combining real-time oscillation analysis with cortico-cortical evoked potentials for awake craniotomy.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


  179. MOON JH, Kim EH, Kim SH
    Snare technique for the remodeling of the redundant arachnoid pouch to prevent cerebrospinal fluid rhinorrhea and hematoma collection during transsphenoidal surgery for suprasellar-extended pituitary tumors.
    J Neurosurg. 2016.
    PubMed     Text format     Abstract available


    December 2015
  180. PLEDGER CL, Elzoghby MA, Oldfield EH, Payne SC, et al
    Prospective comparison of sinonasal outcomes after microscopic sublabial or endoscopic endonasal transsphenoidal surgery for nonfunctioning pituitary adenomas.
    J Neurosurg. 2015.
    PubMed     Text format     Abstract available


    November 2015
  181. TERPOLILLI NA, Rachinger W, Kunz M, Thon N, et al
    Orbit-associated tumors: navigation and control of resection using intraoperative computed tomography.
    J Neurosurg. 2015.
    PubMed     Text format     Abstract available


  182. SOUTHWELL DG, Hervey-Jumper SL, Perry DW, Berger MS, et al
    Intraoperative mapping during repeat awake craniotomy reveals the functional plasticity of adult cortex.
    J Neurosurg. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: